The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

By P. Moayyedi, A. Ford, N. Talley, F. Cremonini, A. Foxx-Orenstein, L. Brandt, E. M. Quigley. Gut, 2008

743 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Gut Microbes and the Brain: Paradigm Shift in Neuroscience (2014, background): “Several probiotics have been shown to have utility for specific gastrointestinal and global symptoms in irritable bowel syndrome, a chronic pain condition characterized by dysregulation of the brain-gut axis (Moayyedi et al., 2010; Mayer et al., 2014b).”
Mechanisms of Action of Probiotics. (2019, background): “Abbreviations used: ASD, autism spectrum disorder; BCFA, branched-chain fatty acid; BSH, bile salt hydrolase; CD, Crohn disease; CMA, cow-milk allergy; DC, dendritic cell; EFSA, European Food Safety Authority; eHCF, extensively hydrolyzed casein formula; FoxP3, forkhead box P3; GPR, G protein–couple”
Probiotics and the gut microbiota in intestinal health and disease (2010, background): “In a systematic review of the literature, various lactobacilli species, when taken either alone or co-administered with bifidobacteria, resulted in an improvement in symptoms in patients with IBS”
Probiotics, gut microbiota, and their influence on host health and disease (2017, positive): “For that, different probiotic intervention studies have been performed in last few years and although the results suggest that there is a benefit of probiotic use in the relief of IBS symptoms [37, 48], welldesigned, placebo-controlled studies are recommended since each probiotic strain has unique f”